췌장암의 외과적 치료

• Published in: Taehan Ŭisa Hyŏphoe chi pp. 377 - 382
• Main Author: 양재도
• Format: Journal Article
• Language: Korean
• Published: 대한의사협회 01.06.2025
• Subjects: 기타의약학
• ISSN: 1975-8456
• DOI: 10.5124/jkma.25.0074

췌장암 수술 377 © Korean Medical Association This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/ by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. Purpose: Pancreatic cancer (PC) is among the most aggressive gastrointestinal malignancies, characterized by rapid progression and early metastatic spread, resulting in a poor prognosis for affected patients. This review provides an overview of the various surgical options for PC, highlights key perioperative considerations, and discusses recent advances in the field. Current Concepts: Pancreatectomy is classified according to tumor location as distal, pancreaticoduodenectomy, or total. Three surgical stages have been established for a preoperative assessment based on resectability: resectable, borderline resectable, and unresectable. Discussion and Conclusion: The use of minimally invasive surgery for PC is increasing. Although upfront surgery followed by adjuvant chemotherapy remains the standard treatment for resectable PC, accumulating evidence suggests that neoadjuvant chemotherapy improves overall survival in borderline resectable cases, even though it does not increase resection rates. KCI Citation Count: 0